Try our mobile app

Switch to company model in "Rising Stars" logic    *

General information

Country: UNITED STATES

Sector: Biotechnology

Veracyte, Inc. develops molecular tests for oncology. The Company offers molecular cytology and tests for the diagnostic accuracy of cytology samples. Veracyte provides its products and services to healthcare and molecular diagnostic companies in the United States.
Website: veracyte.com


  • Good financial results growth rate 34.7% (average between last period year over year growth for revenue and EBITDA), there is acceleration compared to average historical growth rates (10.2%)
  • Dividend yield for the last twelve months 0.0%
  • Free cash flow yield 2.3% (LTM)
  • Share price is 115.1% higher than minimum and 17.8% lower than maximum for the last 3 years
  • The company is overvalued by EV / LTM EBITDA multiple compared to target level (62.3x vs 30.0x)
  • Fundamental value created in LTM (estimate)
  • For the last 3 months insiders sold company shares on $3.1 mln (-0.087% of cap.)

Key Financials (Download financials)

Ticker: VCYT
Share price, USD:  (0.0%)40.57
year average price 33.96  


year start price 39.59 2025-02-13

min close price 23.03 2025-07-21

max close price 49.38 2025-11-25

current price 40.57 2026-02-13
Common stocks: 78 725 139

Dividend Yield:  0.0%
FCF Yield LTM: 2.3%
EV / LTM EBITDA: 62.3x
EV / EBITDA annualized: 25.6x
Last revenue growth (y/y):  +13.8%
Last growth of EBITDA (y/y):  +55.6%
Historical revenue growth:  +20.4%
Historical growth of EBITDA:  0.0%
EV / Sales: 5.8x
Margin (EBITDA LTM / Revenue): 9.3%

Target EV / EBITDA (hist percentile): 30.0x
Express share price potential:
Fundamental value created in LTM:
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 3 194
Net Debt ($m): -326
EV (Enterprise Value): 2 868
EBITDA LTM (млн $): 46
EV / LTM EBITDA: 62.3x
Price to Book: 2.5x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / EBITDA

Potential dynamics

News


2026-01-30zacks.com

Here's Why Veracyte (VCYT) Is a Great 'Buy the Bottom' Stock Now

2026-01-26zacks.com

Why Veracyte (VCYT) is Poised to Beat Earnings Estimates Again

2026-01-22zacks.com

Why Veracyte (VCYT) is a Top Momentum Stock for the Long-Term

2026-01-16seekingalpha.com

Veracyte: Profitable, De-Risked, And Ready To Run

2026-01-15seekingalpha.com

Veracyte, Inc. (VCYT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

2025-12-29businesswire.com

Veracyte to Participate in the 44th Annual J.P. Morgan Healthcare Conference

2025-12-23zacks.com

Is This the Right Time to Add Veracyte Stock to Your Portfolio?

2025-12-02zacks.com

Why Veracyte (VCYT) is a Top Growth Stock for the Long-Term

2025-11-11zacks.com

VCYT Stock Gains on Q3 Earnings and Revenue Beat, '25 View Up

2025-11-04seekingalpha.com

Veracyte, Inc. (VCYT) Q3 2025 Earnings Call Transcript
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol VCYT VCYT VCYT VCYT VCYT VCYT VCYT VCYT VCYT VCYT VCYT VCYT VCYT VCYT
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-11-05 2025-08-07 2024-11-07 2024-08-07 2024-05-08 2023-11-08 2023-08-09 2023-05-05 2022-11-03
acceptedDate 2025-11-05 08:15:57 2025-08-07 16:41:08 2025-02-27 21:58:16 2024-11-07 08:01:01 2024-08-07 08:11:25 2024-05-08 17:03:22 2024-02-29 08:06:41 2023-11-08 08:30:57 2023-08-09 16:07:39 2023-05-05 08:07:27 2023-02-28 17:48:53 2022-11-03 07:57:44 2022-02-28 16:40:48 2021-02-22 16:18:16
calendarYear 2025 2025 2024 2024 2023 2023 2023 2022 2022
period Q3 Q2 FY Q2 Q1 Q4 FY Q2 Q1 Q4 FY Q3 FY FY
revenue 132M 130M 446M 116M 114M 97M 361M 90M 90M 82M 297M 76M 220M 117M
costOfRevenue 43M 40M 148M 37M 39M 36M 113M 28M 30M 26M 102M 26M 74M 41M
grossProfit 89M 90M 298M 79M 76M 61M 248M 62M 61M 56M 195M 50M 145M 76M
grossProfitRatio 0.678 0.69 0.682 0.662 0.625 0.694 0.671 0.682 0.656
researchAndDevelopmentExpenses 16M 16M 69M 18M 16M 16M 57M 13M 13M 13M 41M 11M 30M 17M
generalAndAdministrativeExpenses 0 14M 178M 26M 48M 43M 158M 16M 25M 22M 77M 18M 101M 37M
sellingAndMarketingExpenses 0 43M 28M 23M 7M 6M 27M 24M 26M 26M 98M 26M 80M 52M
sellingGeneralAndAdministrativeExpenses 51M 57M 206M 48M 55M 49M 184M 41M 51M 49M 174M 43M 181M 89M
otherExpenses 0 22M 7M 0 -125 000 43 000 92M 40M -226 000 5M 21M 5M 16M 5M
operatingExpenses 66M 95M 282M 66M 71M 65M 334M 94M 69M 67M 236M 59M 227M 111M
costAndExpenses 109M 135M 430M 103M 110M 101M 447M 122M 98M 93M 338M 85M 301M 153M
interestIncome 3M 3M 11M 3M 3M 3M 7M 2M 1M 1M 2M 573 000 135 000 594 000
interestExpense 0 0 2000 1000 1000 0 15 000 2000 3000 7000 198 000 61 000 241 000 229 000
depreciationAndAmortization 5M 5M 23M 6M 6M 6M 27M 7M 7M 7M 29M 6M 21M 8M
ebitda 24M 7M 49M 23M 11M 1M -49M 45M -1M -4M -7M -3M -60M -27M
ebitdaratio 0.183 0.052 0.196 0.091 0.014 0.504 -0.013 -0.046 -0.044
operatingIncome 23M -5M 16M 12M 5M -4M -86M -32M -8M -10M -41M -10M -82M -35M
operatingIncomeRatio 0.175 -0.04 0.104 0.041 -0.044 -0.352 -0.089 -0.127 -0.128
totalOtherIncomeExpensesNet -4M 7M 10M 5M 3M 2M 9M 2M -226 000 2M 5M 805 000 254 000 480 000
incomeBeforeTax 19M 1M 26M 17M 7M -2M -77M -30M -8M -8M -36M -9M -82M -35M
incomeBeforeTaxRatio 0.143 0.01 0.145 0.064 -0.02 -0.33 -0.092 -0.098 -0.117
incomeTaxExpense -248 000 2M 2M 2M 2M -44 000 -2M -154 000 125 000 -2M 133 000 -152 000 -6M 0
netIncome 19M -980 000 24M 15M 6M -2M -74M -30M -8M -6M -37M -9M -76M -35M
netIncomeRatio 0.145 -0.008 0.131 0.05 -0.019 -0.329 -0.093 -0.069 -0.115
eps 0.243 -0.013 0.32 0.2 0.075 -0.025 -1.02 -0.41 -0.12 -0.079 -0.51 -0.12 -1.11 -0.66
epsdiluted 0.24 -0.013 0.19 0.074 -0.025 -0.41 -0.12 -0.079 -0.12
weightedAverageShsOut 79M 78M 76M 77M 77M 75M 73M 73M 72M 72M 72M 72M 68M 53M
weightedAverageShsOutDil 80M 80M 78M 78M 77M 75M 73M 73M 72M 72M 72M 72M 68M 53M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-28 2024-02-29 2023-03-01 2022-02-28 2021-02-22
fiscalYear 2024 2023 2022 2021 2020
netInterestIncome 11M 7M 2M -106 000 365 000
ebit 26M -77M -36M -81M -35M
nonOperatingIncomeExcludingInterest -10M -9M -5M -495 000 -709 000
netIncomeFromContinuingOperations 24M -74M -37M -76M -35M
netIncomeFromDiscontinuedOperations 0 0 0 0 0
otherAdjustmentsToNetIncome 0 0 0 0 0
netIncomeDeductions 0 0 0 0 0
bottomLineNetIncome 24M -74M -37M -76M -35M
epsDiluted 0.31 -1.02 -0.51 -1.11 -0.66

Balance Sheet Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol VCYT VCYT VCYT VCYT VCYT VCYT VCYT VCYT VCYT VCYT VCYT VCYT VCYT VCYT
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-11-05 2025-08-07 2024-11-07 2024-08-07 2024-05-08 2023-11-08 2023-08-09 2023-05-05 2022-11-03
acceptedDate 2025-11-05 08:15:57 2025-08-07 16:41:08 2025-02-27 21:58:16 2024-11-07 08:01:01 2024-08-07 08:11:25 2024-05-08 17:03:22 2024-02-29 08:06:41 2023-11-08 08:30:57 2023-08-09 16:07:39 2023-05-05 08:07:27 2023-02-28 17:48:53 2022-11-03 07:57:44 2022-02-28 16:40:48 2021-02-22 16:18:16
calendarYear 2025 2025 2024 2024 2023 2023 2023 2022 2022
period Q3 Q2 FY Q2 Q1 Q4 FY Q2 Q1 Q4 FY Q3 FY FY
cashAndCashEquivalents 316M 219M 239M 274M 236M 209M 216M 202M 191M 178M 154M 170M 173M 349M
shortTermInvestments 51M 101M 50M 0 0 0 0 0 0 0 25M 0 4M 0
cashAndShortTermInvestments 366M 321M 289M 274M 236M 209M 216M 202M 191M 178M 179M 170M 177M 349M
netReceivables 48M 51M 47M 49M 50M 47M 40M 39M 42M 45M 44M 40M 41M 18M
inventory 20M 25M 22M 20M 19M 18M 16M 16M 12M 13M 14M 14M 11M 5M
otherCurrentAssets 15M 18M 15M 14M 16M 16M 13M 14M 14M 15M 11M 15M -4M 0
totalCurrentAssets 449M 415M 372M 357M 321M 290M 286M 271M 259M 252M 249M 239M 243M 376M
propertyPlantEquipmentNet 56M 57M 71M 38M 40M 33M 31M 31M 31M 29M 31M 31M 31M 17M
goodwill 767M 773M 746M 762M 752M 754M 703M 693M 699M 700M 696M 677M 708M 3M
intangibleAssets 92M 96M 102M 109M 113M 116M 89M 124M 165M 170M 175M 177M 203M 60M
goodwillAndIntangibleAssets 860M 869M 848M 871M 865M 870M 792M 817M 864M 870M 871M 853M 911M 63M
longTermInvestments 2M 0 0 0 1M 1M 0 870 000 0 0 0 0 0 0
taxAssets 0 0 0 0 0 1 0 -870 000 0 0 0 0 0 0
otherNonCurrentAssets 1M 3M 9M 9M 7M 6M 7M 6M 7M 6M 6M 3M 3M 2M
totalNonCurrentAssets 919M 929M 928M 918M 913M 910M 829M 854M 902M 906M 908M 887M 945M 81M
otherAssets 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalAssets 1 368M 1 344M 1 300M 1 275M 1 234M 1 200M 1 115M 1 125M 1 161M 1 157M 1 156M 1 126M 1 188M 457M
accountPayables 6M 11M 9M 10M 12M 12M 13M 13M 13M 16M 12M 11M 12M 3M
shortTermDebt 4M 6M 0 7M 14M 6M 0 5M 5M 4M 0 5M 1M 0
taxPayables 0 0 0 0 0 0 0 0 0 0 0 0 0 0
deferredRevenue 417 000 1M 2M 2M 2M 3M 2M 2M 2M 2M 3M 4M 5M 371 000
otherCurrentLiabilities 62M 57M 48M 51M 44M 37M 29M 38M 38M 34M 37M 38M 34M 9M
totalCurrentLiabilities 72M 76M 79M 70M 72M 58M 61M 57M 58M 56M 63M 58M 64M 17M
longTermDebt 36M 44M 0 12M 14M 8M 0 9M 10M 10M 0 12M 0 810 000
deferredRevenueNonCurrent 0 0 0 0 0 0 0 0 0 0 0 0 343 000 829 000
deferredTaxLiabilitiesNonCurrent 1M 1M 1M 1M 1M 1M 734 000 4M 5M 5M 5M 4M 6M 0
otherNonCurrentLiabilities 583 000 1M 972 000 15M 14M 14M 1M 1M 6M 6M 3M -694 000 7M 8M
totalNonCurrentLiabilities 38M 47M 45M 29M 29M 23M 10M 14M 20M 20M 19M 19M 27M 19M
otherLiabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0
capitalLeaseObligations 36M 51M 51M 20M 21M 8M 13M 14M 15M 14M 15M 15M 18M 12M
totalLiabilities 110M 123M 124M 99M 102M 81M 71M 71M 78M 76M 81M 78M 91M 36M
preferredStock 0 0 0 0 0 499M 0 474M 438M 0 0 0 0 0
commonStock 79 000 79 000 78 000 77 000 77 000 76 000 73 000 73 000 73 000 72 000 72 000 72 000 71 000 58 000
retainedEarnings -419M -438M -444M -449M -464M -470M -468M -440M -410M -402M -394M -390M -357M -282M
accumulatedOtherComprehensiveIncomeLoss -8M -12M -36M -21M -31M -29M -24M -34M -28M -27M -31M -54M -15M 0
othertotalStockholdersEquity 1 685M 1 671M 1 646M 1 627M 1 119M 1 054M 1 083M 1 510M 1 492M
totalStockholdersEquity 1 258M 1 221M 1 176M 1 176M 1 133M 1 119M 1 044M 1 054M 1 083M 1 081M 1 075M 1 048M 1 097M 421M
totalEquity 1 258M 1 221M 1 176M 1 176M 1 133M 1 119M 1 044M 1 054M 1 083M 1 081M 1 075M 1 048M 1 097M 421M
totalLiabilitiesAndStockholdersEquity 1 368M 1 344M 1 275M 1 234M 1 200M 1 125M 1 161M 1 157M 1 126M
minorityInterest 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalLiabilitiesAndTotalEquity 1 368M 1 344M 1 300M 1 275M 1 234M 1 200M 1 115M 1 125M 1 161M 1 157M 1 156M 1 126M 1 188M 457M
totalInvestments 52M 101M 50M 0 1M 1M 0 870 000 0 0 25M 0 4M 0
totalDebt 40M 51M 51M 20M 21M 14M 13M 14M 15M 14M 15M 17M 19M 12M
netDebt -275M -169M -188M -254M -215M -195M -204M -189M -176M -164M -140M -153M -154M -337M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-28 2024-02-29 2023-03-01 2022-02-28 2021-02-22
fiscalYear 2024 2023 2022 2021 2020
accountsReceivables 47M 40M 44M 41M 18M
otherReceivables 0 0 0 0 0
prepaids 0 0 0 17M 3M
totalPayables 9M 13M 12M 12M 3M
otherPayables 0 0 0 0 0
accruedExpenses 13M 12M 7M 9M 3M
capitalLeaseObligationsCurrent 8M 5M 4M 4M 2M
capitalLeaseObligationsNonCurrent 43M 8M 11M 14M 10M
treasuryStock 0 0 0 0 0
additionalPaidInCapital 1 656M 1 536M 1 500M 1 469M 703M
otherTotalStockholdersEquity 0 0 0 0 0

Cash Flow Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol VCYT VCYT VCYT VCYT VCYT VCYT VCYT VCYT VCYT VCYT VCYT VCYT VCYT VCYT
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-11-05 2025-08-07 2024-11-07 2024-08-07 2024-05-08 2023-11-08 2023-08-09 2023-05-05 2022-11-03
acceptedDate 2025-11-05 08:15:57 2025-08-07 16:41:08 2025-02-27 21:58:16 2024-11-07 08:01:01 2024-08-07 08:11:25 2024-05-08 17:03:22 2024-02-29 08:06:41 2023-11-08 08:30:57 2023-08-09 16:07:39 2023-05-05 08:07:27 2023-02-28 17:48:53 2022-11-03 07:57:44 2022-02-28 16:40:48 2021-02-22 16:18:16
calendarYear 2025 2025 2024 2024 2023 2023 2023 2022 2022
period Q3 Q2 FY Q2 Q1 Q4 FY Q2 Q1 Q4 FY Q3 FY FY
netIncome 19M -980 000 24M 15M 6M -2M -74M -30M -8M -8M -37M -9M -76M -35M
depreciationAndAmortization 5M 5M 23M 6M 6M 6M 27M 7M 7M 7M 26M 6M 20M 8M
deferredIncomeTax -87 000 59 000 -233 000 -13 000 143 000 -120 000 -4M -968 000 125 000 0 133 000 -152 000 -6M 0
stockBasedCompensation 11M 11M 36M 9M 10M 8M 33M 7M 10M 8M 27M 7M 23M 13M
changeInWorkingCapital 6M 1M -21M 17M 6M -23M -4M -2M 6M -10M -16M 504 000 4M -481 000
accountsReceivables 425 000 3M -6M 2M -4M -6M 4M 3M 3M -1M -4M -1M -9M 955 000
inventory 221 000 -565 000 -6M -909 000 -963 000 -2M -2M -4M 2M 1M -3M 813 000 -1M 1M
accountsPayables -4M -4M -4M -1M -162 000 -2M -134 000 -607 000 -1M 2M 152 000 1M 5M 711 000
otherWorkingCapital 9M 3M -5M 17M 11M -13M -6M 614 000 3M -2M -9M 63 000 9M -3M
otherNonCashItems 3M 17M 13M -17M 28M 32M 66M 32M 1M 2M 8M 2M 4M 5M
netCashProvidedByOperatingActivities 45M 34M 75M 30M 30M -9M 44M 14M 17M -2M 8M 7M -32M -10M
investmentsInPropertyPlantAndEquipment -3M -1M -11M -2M -3M -2M -10M -3M -4M -993 000 -9M -2M -5M -3M
acquisitionsNet 0 0 5M 0 0 5M 0 0 0 0 0 0 -737M 0
purchasesOfInvestments 0 -50M -50M 0 0 0 -20M 0 0 -20M -34M 0 162M -1 000 000
salesMaturitiesOfInvestments 51M 0 0 0 0 0 45M 0 0 45M 13M 11M 3M 0
otherInvestingActivites 0 51M 0 0 0 0 0 0 0
netCashUsedForInvestingActivites 48M -224 000 -2M -3M 3M -3M -4M 24M 9M
debtRepayment 0 0 0 0 0 0 0 0 -3000
commonStockIssued 6M 0 -4M 1M 3M 3M 0 4M 0
commonStockRepurchased 0 0 0 5M -1M -4M 0 -2M 0 0 0 0 0 0
dividendsPaid 0 0 0 0 0 0 0 0 0
otherFinancingActivites -3M -566 000 10M -11 000 -4M -2M 397 000 -2M 1M
netCashUsedProvidedByFinancingActivities 3M -566 000 10M -11 000 -864 000 110 000 397 000 2M 1M
effectOfForexChangesOnCash 77 000 573 000 -424 000 146 000 -61 000 -108 000 163 000 -177 000 -7000 50 000 -592 000 -654 000 -2M 0
netChangeInCash 96M 33M 23M 39M 27M -7M 62M 11M 13M 24M -19M 17M -176M 190M
cashAtEndOfPeriod 316M 221M 241M 275M 236M 209M 217M 203M 192M 179M 155M 171M 174M 350M
cashAtBeginningOfPeriod 219M 188M 217M 237M 209M 216M 155M 192M 179M 155M 174M 154M 350M 160M
operatingCashFlow 45M 34M 75M 30M 30M -9M 44M 14M 17M -2M 8M 7M -32M -10M
capitalExpenditure -3M -1M -11M -2M -3M -2M -10M -3M -4M -993 000 -9M -2M -5M -3M
freeCashFlow 42M 32M 64M 28M 27M -11M 34M 11M 13M -3M -1M 5M -37M -13M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-28 2024-02-29 2023-03-01 2022-02-28 2021-02-22
fiscalYear 2024 2023 2022 2021 2020
otherInvestingActivities 0 0 0 -162M 0
netCashProvidedByInvestingActivities -56M 15M -29M -739M -4M
netDebtIssuance 0 0 -1M 0 -100 000
longTermNetDebtIssuance 0 0 -1M 0 -100 000
shortTermNetDebtIssuance 0 0 0 0 0
netStockIssuance 20M 0 0 594M 194M
netCommonStockIssuance 20M 0 0 594M 194M
commonStockIssuance 20M 0 0 594M 194M
netPreferredStockIssuance 0 0 0 0 0
netDividendsPaid 0 0 0 0 0
commonDividendsPaid 0 0 0 0 0
preferredDividendsPaid 0 0 0 0 0
otherFinancingActivities -15M 3M 5M 2M 10M
netCashProvidedByFinancingActivities 5M 3M 3M 596M 204M
incomeTaxesPaid 2M 2M 570 000 112 000 112 000
interestPaid 0 0 9000 9000 13 000

Earning call transcript

2025 q3
2025-11-04 ET (fiscal 2025 q3)
2025 q2
2025-08-07 ET (fiscal 2025 q2)
2025 q1
2025-05-08 ET (fiscal 2025 q1)
2024 q4
2025-02-24 ET (fiscal 2024 q4)
2024 q3
2024-11-06 ET (fiscal 2024 q3)
2024 q2
2024-08-06 ET (fiscal 2024 q2)
2024 q1
2024-05-07 ET (fiscal 2024 q1)
2023 q4
2024-02-22 ET (fiscal 2023 q4)
2023 q3
2023-11-07 ET (fiscal 2023 q3)
2023 q2
2023-08-08 ET (fiscal 2023 q2)
2023 q1
2023-05-04 ET (fiscal 2023 q1)
2022 q4
2023-02-23 ET (fiscal 2022 q4)
2022 q3
2022-11-02 ET (fiscal 2022 q3)
2022 q2
2022-08-02 ET (fiscal 2022 q2)
2022 q1
2022-05-03 ET (fiscal 2022 q1)

SEC forms

Show financial reports only

SEC form 8
2025-11-04 16:08 ET
Veracyte published news for 2025 q3
SEC form 8
2025-11-04 16:08 ET
Veracyte reported for 2025 q3
SEC form 10
2025-08-07 20:41 ET
Veracyte reported for 2025 q2
SEC form 8
2025-08-06 20:08 ET
Veracyte published news for 2025 q2
SEC form 8
2025-08-06 20:08 ET
Veracyte published news for 2025 q2
SEC form 10
2025-05-08 12:06 ET
Veracyte published news for 2025 q1
SEC form 10
2025-05-08 00:00 ET
Veracyte published news for 2025 q1
SEC form 8
2025-05-07 20:07 ET
Veracyte published news for 2025 q1
SEC form 8
2025-05-07 20:07 ET
Veracyte reported for 2025 q1
SEC form 10
2025-02-28 02:58 ET
Veracyte published news for 2024 q4
SEC form 10
2025-02-28 00:00 ET
Veracyte published news for 2024 q4
SEC form 8
2025-02-24 16:11 ET
Veracyte published news for 2024 q4
SEC form 8
2025-02-24 16:11 ET
Veracyte reported for 2024 q4
SEC form 10
2024-11-07 08:01 ET
Veracyte published news for 2024 q3
SEC form 8
2024-11-06 16:11 ET
Veracyte published news for 2024 q3
SEC form 8
2024-11-06 16:11 ET
Veracyte published news for 2024 q3
SEC form 10
2024-08-07 08:11 ET
Veracyte published news for 2024 q2
SEC form 10
2024-08-07 00:00 ET
Veracyte published news for 2024 q2
SEC form 8
2024-08-06 16:16 ET
Veracyte published news for 2024 q2
SEC form 8
2024-08-06 16:16 ET
Veracyte reported for 2024 q2
SEC form 10
2024-05-08 00:00 ET
Veracyte published news for 2024 q1
SEC form 8
2024-05-07 16:10 ET
Veracyte published news for 2024 q1
SEC form 8
2024-05-07 16:10 ET
Veracyte reported for 2024 q1
SEC form 10
2024-02-29 00:00 ET
Veracyte published news for 2023 q4
SEC form 8
2024-02-22 16:12 ET
Veracyte published news for 2023 q4
SEC form 8
2024-02-22 16:12 ET
Veracyte reported for 2023 q4
SEC form 8
2024-01-08 00:00 ET
Veracyte published news for 2023 q4
SEC form 8
2024-01-08 00:00 ET
Veracyte published news for 2023 q4
SEC form 10
2023-11-08 08:30 ET
Veracyte published news for 2023 q3
SEC form 10
2023-11-08 00:00 ET
Veracyte published news for 2023 q3
SEC form 8
2023-11-07 16:09 ET
Veracyte reported for 2023 q3
SEC form 10
2023-08-09 16:07 ET
Veracyte published news for 2023 q2
SEC form 10
2023-08-09 00:00 ET
Veracyte published news for 2023 q2
SEC form 6
2023-08-08 16:11 ET
Veracyte reported for 2023 q2
SEC form 8
2023-08-08 00:00 ET
Veracyte published news for 2023 q2
SEC form 6
2023-06-09 17:01 ET
Veracyte published news for 2023 q1
SEC form 10
2023-05-05 00:00 ET
Veracyte published news for 2023 q1
SEC form 8
2023-05-04 00:00 ET
Veracyte published news for 2023 q1
SEC form 10
2023-03-01 00:00 ET
Veracyte reported for 2022 q4
SEC form 10
2023-02-28 17:48 ET
Veracyte reported for 2022 q4
SEC form 6
2023-02-22 16:08 ET
Veracyte published news for 2022 q4
SEC form 8
2023-02-22 00:00 ET
Veracyte reported for 2022 q4
SEC form 6
2023-02-10 16:44 ET
Veracyte published news for 2022 q4
SEC form 6
2022-12-14 08:25 ET
Veracyte published news for 2022 q3
SEC form 10
2022-11-03 07:57 ET
Veracyte reported for 2022 q3
SEC form 10
2022-11-03 00:00 ET
Veracyte reported for 2022 q3
SEC form 6
2022-11-02 16:11 ET
Veracyte published news for 2022 q3
SEC form 8
2022-11-02 00:00 ET
Veracyte reported for 2022 q3
SEC form 6
2022-09-07 16:56 ET
Veracyte published news for 2022 q2
SEC form 6
2022-08-11 16:26 ET
Veracyte published news for 2022 q2
SEC form 6
2022-08-11 16:24 ET
Veracyte published news for 2022 q2
SEC form 6
2022-08-09 17:19 ET
Veracyte published news for 2022 q2
SEC form 6
2022-08-09 17:17 ET
Veracyte published news for 2022 q2
SEC form 6
2022-08-09 17:16 ET
Veracyte published news for 2022 q2
SEC form 6
2022-08-09 17:16 ET
Veracyte published news for 2022 q2
SEC form 10
2022-08-03 08:01 ET
Veracyte reported for 2022 q2
SEC form 10
2022-08-03 00:00 ET
Veracyte reported for 2022 q2
SEC form 6
2022-08-02 16:15 ET
Veracyte published news for 2022 q2
SEC form 8
2022-08-02 00:00 ET
Veracyte reported for 2022 q2
SEC form 6
2022-06-16 20:12 ET
Veracyte published news for 2022 q1
SEC form 6
2022-06-16 20:12 ET
Veracyte published news for 2022 q1
SEC form 6
2022-06-16 20:12 ET
Veracyte published news for 2022 q1
SEC form 6
2022-06-16 20:11 ET
Veracyte published news for 2022 q1
SEC form 6
2022-06-16 20:06 ET
Veracyte published news for 2022 q1
SEC form 6
2022-06-16 20:04 ET
Veracyte published news for 2022 q1
SEC form 6
2022-06-16 16:15 ET
Veracyte published news for 2022 q1
SEC form 10
2022-05-04 00:00 ET
Veracyte reported for 2022 q1
SEC form 10
2022-05-03 17:57 ET
Veracyte reported for 2022 q1
SEC form 6
2022-05-03 16:12 ET
Veracyte published news for 2022 q1
SEC form 8
2022-05-03 00:00 ET
Veracyte reported for 2022 q1
SEC form 6
2022-04-26 16:14 ET
Veracyte published news for 2022 q1
SEC form 6
2022-03-03 20:27 ET
Veracyte published news for 2021 q4
SEC form 10
2022-02-28 16:40 ET
Veracyte published news for 2021 q4
SEC form 6
2022-02-28 16:11 ET
Veracyte published news for 2021 q4
SEC form 10
2022-02-28 00:00 ET
Veracyte published news for 2021 q4
SEC form 8
2022-02-28 00:00 ET
Veracyte published news for 2021 q4
SEC form 6
2022-02-22 16:40 ET
Veracyte published news for 2021 q4
SEC form 6
2022-01-13 16:47 ET
Veracyte published news for 2021 q4
SEC form 6
2022-01-11 16:50 ET
Veracyte published news for 2021 q4
SEC form 10
2021-11-09 16:37 ET
Veracyte published news for 2021 q3
SEC form 6
2021-11-09 16:11 ET
Veracyte published news for 2021 q3
SEC form 10
2021-11-09 00:00 ET
Veracyte published news for 2021 q3
SEC form 8
2021-11-09 00:00 ET
Veracyte published news for 2021 q3
SEC form 6
2021-08-04 16:14 ET
Veracyte published news for 2021 q2
SEC form 6
2021-08-03 08:09 ET
Veracyte published news for 2021 q2
SEC form 10
2021-07-29 16:19 ET
Veracyte published news for 2021 q2
SEC form 6
2021-07-29 16:16 ET
Veracyte published news for 2021 q2
SEC form 10
2021-07-29 00:00 ET
Veracyte published news for 2021 q2
SEC form 8
2021-07-29 00:00 ET
Veracyte published news for 2021 q2
SEC form 6
2021-07-20 16:44 ET
Veracyte published news for 2021 q2
SEC form 6
2021-07-16 09:02 ET
Veracyte published news for 2021 q2
SEC form 6
2021-07-13 16:58 ET
Veracyte published news for 2021 q2
SEC form 6
2021-07-12 08:37 ET
Veracyte published news for 2021 q2
SEC form 6
2021-06-10 16:21 ET
Veracyte published news for 2021 q1
SEC form 6
2021-06-10 16:20 ET
Veracyte published news for 2021 q1
SEC form 6
2021-06-10 16:18 ET
Veracyte published news for 2021 q1
SEC form 6
2021-06-10 16:16 ET
Veracyte published news for 2021 q1
SEC form 6
2021-06-10 16:12 ET
Veracyte published news for 2021 q1
SEC form 6
2021-06-10 16:11 ET
Veracyte published news for 2021 q1
SEC form 6
2021-06-08 16:40 ET
Veracyte published news for 2021 q1
SEC form 6
2021-06-08 16:38 ET
Veracyte published news for 2021 q1
SEC form 6
2021-06-08 16:35 ET
Veracyte published news for 2021 q1
SEC form 6
2021-06-03 17:00 ET
Veracyte published news for 2021 q1
SEC form 6
2021-06-01 07:16 ET
Veracyte published news for 2021 q1
SEC form 6
2021-05-19 17:16 ET
Veracyte published news for 2021 q1
SEC form 10
2021-05-10 16:23 ET
Veracyte published news for 2021 q1
SEC form 6
2021-05-10 16:17 ET
Veracyte published news for 2021 q1
SEC form 10
2021-05-10 00:00 ET
Veracyte published news for 2021 q1
SEC form 8
2021-05-10 00:00 ET
Veracyte published news for 2021 q1
SEC form 6
2021-04-23 16:12 ET
Veracyte published news for 2021 q1
SEC form 6
2021-04-15 16:55 ET
Veracyte published news for 2021 q1
SEC form 8
2021-04-15 00:00 ET
Veracyte published news for 2021 q1
SEC form 6
2021-04-05 16:58 ET
Veracyte published news for 2021 q1
SEC form 6
2021-04-05 16:50 ET
Veracyte published news for 2021 q1
SEC form 6
2021-03-23 16:38 ET
Veracyte published news for 2020 q4
SEC form 6
2021-03-22 09:21 ET
Veracyte published news for 2020 q4
SEC form 6
2021-03-15 16:23 ET
Veracyte published news for 2020 q4
SEC form 6
2021-03-03 16:07 ET
Veracyte published news for 2020 q4
SEC form 10
2021-02-22 16:18 ET
Veracyte published news for 2020 q4
SEC form 6
2021-02-17 16:17 ET
Veracyte published news for 2020 q4
SEC form 6
2021-02-05 06:17 ET
Veracyte published news for 2020 q4
SEC form 6
2021-02-03 08:21 ET
Veracyte published news for 2020 q4
SEC form 6
2021-01-25 08:33 ET
Veracyte published news for 2020 q4
SEC form 6
2020-12-16 17:14 ET
Veracyte published news for 2020 q3
SEC form 6
2020-11-17 16:39 ET
Veracyte published news for 2020 q3
SEC form 10
2020-11-02 16:20 ET
Veracyte published news for 2020 q3
SEC form 6
2020-11-02 16:15 ET
Veracyte published news for 2020 q3